Literature DB >> 13084756

Nutritive adequacy and clinical tolerance of modified human globin.

G J GABUZDA, G B PHILLIPS, C S DAVIDSON.   

Abstract

Entities:  

Keywords:  HEMOGLOBIN; PROTEINS

Mesh:

Substances:

Year:  1953        PMID: 13084756      PMCID: PMC438419          DOI: 10.1172/JCI102808

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  7 in total

1.  Distribution and fate of intravenously administered modified human globin and its effect on blood volume; studies utilizing I131 tagged globin.

Authors:  S A BERSON; R S YALOW; J POST; L H WISHAM; K N NEWERLY; M J VILLAZON; O N VAZQUEZ
Journal:  J Clin Invest       Date:  1953-01       Impact factor: 14.808

2.  The turnover rate of serum albumin in man as measured by I131-tagged albumin.

Authors:  K STERLING
Journal:  J Clin Invest       Date:  1951-11       Impact factor: 14.808

3.  Effects of modified human globin in normal human subjects.

Authors:  J L BRANDT; A CACCESE; V GINSBERG
Journal:  Proc Soc Exp Biol Med       Date:  1951-05

4.  Modified globin. I. Method for preparation from human erythrocytes.

Authors:  M M STRUMIA; A B SAMPLE
Journal:  J Lab Clin Med       Date:  1951-06

5.  Modified globin. III. Determination of modified human globin in blood serum and in urine.

Authors:  A B SAMPLE; M M STRUMIA; V SATTA
Journal:  J Lab Clin Med       Date:  1952-08

6.  Modified globin. IV. Some of the physiological properties of modified human globin.

Authors:  M M STRUMIA; J J McGRAW; A B SAMPLE
Journal:  J Lab Clin Med       Date:  1952-08

7.  Studies of the effects of modified human globin in man.

Authors:  C S DAVIDSON
Journal:  Int Rec Med Gen Pract Clin       Date:  1952-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.